Yu Huang

Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study

Kunyu Yang, Yuhan Sheng, Chaolin Huang et al. · The Lancet Oncology · 2020 · 600 citations · Full text

Medicine, Health Sciences, Oncology +16

miR-143 inhibits interleukin-13-induced inflammatory cytokine and mucus production in nasal epithelial cells from allergic rhinitis patients by targeting IL13Rα1

Yaoshu Teng, Ruxin Zhang, Chunhui Liu et al. · Biochemical and Biophysical Research Communications · 2014 · 78 citations

Life Sciences, Immunology, Otolaryngology +16

Transforming growth factor-β1 upregulates the expression of CXC chemokine receptor 4 (CXCR4) in human breast cancer MCF-7 cells

Xiaoping Zhao, Yongyao Huang, Yu Huang et al. · Acta Pharmacologica Sinica · 2010 · 58 citations · Full text

Life Sciences, Cell Biology, Oncology +13

Derp1-modified dendritic cells attenuate allergic inflammation by regulating the development of T helper type1(Th1)/Th2 cells and regulatory T cells in a murine model of allergic rhinitis

Shaoqing Yu, Bing Han, Shuangxi Liu et al. · Molecular Immunology · 2017 · 48 citations

Life Sciences, Immunology, Allergy +16

Effect of miR‐182 on hepatic fibrosis induced by <i>Schistosomiasis japonica</i> by targeting <i>FOXO1</i> through <i>PI3K</i> / <i>AKT</i> signaling pathway

Yu Huang, Xiangxue Fan, Ran Tao et al. · Journal of Cellular Physiology · 2018 · 44 citations

Medicine, Molecular Biology, Pathology +17